The ability to produce complex proteins efficiently is a cornerstone of biotechnology. Among prokaryotic systems, Bacillus subtilis has emerged as a leading candidate for recombinant protein production due to its rapid growth rates, low maintenance costs, and unique protein secretion capabilities. However, its effectiveness in producing eukaryotic proteins that require disulfide bonds presents challenges. Recent advancements in genome reduction and strain optimization have opened new avenues for enhancing the capabilities of B. subtilis, particularly for producing proteins like Gaussia luciferase.
Advantages of Bacillus subtilis
B. subtilis is renowned for its biotechnological applications, particularly in producing industrial enzymes, antibiotics, and other fine chemicals. It thrives in diverse environments, such as soil and plant roots, where it secretes a variety of enzymes. These enzymes play critical roles in nutrient acquisition and protein quality control. The bacterium can yield over 25 g/L of enzymes through optimized industrial processes, primarily via the general protein secretion (Sec) pathway.
Despite its advantages, B. subtilis has limitations, particularly the presence of exoproteases that can degrade heterologous proteins. This degradation can significantly lower the yield of target proteins, necessitating strategies to eliminate or minimize these proteases. Recent strategies include deleting genes responsible for exoprotease production and employing genome reduction techniques to enhance protein secretion.
Genome Reduction Strategies
Genome minimization involves the systematic removal of non-essential genes to create strains better suited for specific applications. This approach has led to the development of midi- and miniBacillus strains, which retain essential functions while eliminating factors that hinder protein production. Strain optimization has also focused on creating sporulation-deficient strains to prevent spore formation during bioprocessing and eliminating prophages that can cause cell lysis under stress.
The production of proteins with multiple disulfide bonds poses additional challenges due to the reducing environment of the bacterial cytoplasm. Disulfide bond formation typically occurs in the endoplasmic reticulum of eukaryotes or in specialized compartments in bacteria. To enhance B. subtilis’s ability to produce such proteins, researchers have integrated recombinant thiol oxidases and modified the expression of disulfide reductases, leading to increased yields of disulfide-bonded proteins.
Gaussia Luciferase as a Model Protein
Gaussia luciferase (GLuc), derived from the bioluminescent copepod Gaussia princeps, serves as an excellent model for studying disulfide bond formation in B. subtilis. GLuc contains five disulfide bonds, making it a challenging target for bacterial expression systems. This study aimed to evaluate the production capacity of genome-reduced B. subtilis strains for GLuc and to benchmark its expression against another disulfide-bonded protein, alkaline phosphatase (PhoA).
The research demonstrated that the genome-reduced strains of B. subtilis outperformed the wild-type strain in GLuc secretion. Notably, the strain with the most significant genome reduction achieved over a 3000-fold increase in active GLuc secretion, even at lower cell densities. This remarkable improvement is attributed to the absence of major extracellular proteases and optimized thiol-disulfide oxidoreductase activity.
Signal Peptide Screening for Enhanced Secretion
To maximize GLuc production, researchers screened various signal peptides (SPs) to identify the best candidates for directing GLuc into the secretion pathway. The study found that specific SPs, particularly those derived from the Epr protein, led to significantly higher GLuc secretion levels in genome-reduced strains. The effectiveness of these SPs highlights the critical role of proper signal peptide selection in optimizing protein production.
Furthermore, the study showed that the GLuc produced by B. subtilis relies entirely on disulfide bond formation for its enzymatic activity. Treatment with reducing agents completely abrogated GLuc activity, confirming the necessity of these bonds for the protein’s functionality.
Overcoming Exoprotease Challenges
The presence of exoproteases in B. subtilis strains poses a significant hurdle for the production of heterologous proteins. In this research, the impact of these proteases on GLuc and PhoA was examined by incubating culture supernatants from the wild-type strain with the proteins produced by the genome-reduced strains. The results indicated that GLuc was highly susceptible to degradation, while PhoA exhibited a more stable profile, suggesting that different strategies may be necessary to protect specific proteins from proteolytic activity.
Conclusion
The advancements in genome reduction and strain optimization have significantly enhanced the capacity of B. subtilis to produce complex, disulfide-bonded proteins like Gaussia luciferase. The study underscores the potential of genome-engineered Bacillus strains as robust expression platforms for challenging eukaryotic proteins. These findings pave the way for further research and development in biopharmaceutical production, where efficient protein expression is crucial.
Key Takeaways
- Genome reduction in B. subtilis enhances the production of disulfide-bonded proteins.
- Proper selection of signal peptides is critical for optimizing protein secretion.
- The absence of extracellular proteases significantly improves yield and stability of target proteins.
- Gaussia luciferase serves as a valuable model for studying protein production in bacterial systems.
- Continued exploration of genome-minimized strains promises advancements in biopharmaceutical manufacturing.
Read more → pmc.ncbi.nlm.nih.gov
